Aledade, launched by former national coordinator for health information technology Farzard Mostashari, MD, is looking to expand its footprint throughout the United States to another 7 states in 2016.
Aledade, launched by former national coordinator for health information technology Farzard Mostashari, MD, is looking to expand its footprint throughout the United States to another 7 states.
The company, which partners with independent primary care physicians to help them create and run accountable care organizations (ACOs), currently is present in 4 states: New York, Maryland, Delaware, and Arkansas. In June, Aledade raised $30 million in Series B funding, and now it has applied to CMS to establish new ACOs in 7 states beginning January 1, 2016.
In 2016, the company will create new ACOs in Florida, Kansas, Louisiana, Mississippi, Tennessee, Virginia, and West Virginia. With ACOs in 11 states, Aledade would cover more than 80,000 Medicare beneficiaries while working with more than 100 practices.
The funding raised in June will support this expansion throughout the US, which Dr Mostashari told AJMC.com at the time.
“Two months ago, we vowed to put our new funding to work by expanding our ACO partnership model to independent primary care physicians across the country,” Dr Mostashari said in a statement. “Today, we are taking another step to fulfill that promise—and to deliver high-quality, value-based care to doctors and patients across the country. We’ve been working with practices in these states for months, and we’re already seeing the power of placing independent primary care doctors at the center of their patients’ care.”
In a Web-based session of The American Journal of Managed Care’s ACO and Emerging Healthcare Delivery Coalition held in June, Travis Broome, MPH, MBA, healthcare policy lead at Aledade, explained that the ACO model is even more timely and pertinent today given CMS’ announced timeline to move to value-based payments and the legislation repealing the sustainable growth rate formula that gives physicians a 5% bonus for participating in alternative Medicare payment models like ACOs.
Each of the new ACOs established by Aledade will be led by a dedicated executive director from the company, who will work with a local physician partner as medical director.
“Partnering with Aledade gives us the capital, tools, and expertise to succeed in the new health care environment, and be rewarded for keeping patients healthy,” Jennifer Brull, MD, who will act as the medical director of Aledade’s Kansas ACO, said. “We’ve already been working with the Aledade team for months, and we can’t wait for official CMS recognition.”
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Prediction Model Identified Risk Factors for ED Visits in Patients With Lung Cancer
December 7th 2023A risk prediction model that was based on machine learning could help to make resource utilization more efficient by correctly predicting emergency department (ED) visits in patients with lung cancer.
Read More